NON-SMALL CELL LUNG CANCER
Clinical trials for NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to overcome resistance in hard-to-treat lung cancer
Disease control CompletedThis early-phase study tested whether adding the drug copanlisib to the standard immunotherapy durvalumab could help patients with stage III non-small cell lung cancer that cannot be removed by surgery. The study included 11 people who had already received chemotherapy and radiat…
Matched conditions: NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Zhonglin Hao • Aim: Disease control
Last updated Apr 28, 2026 23:52 UTC
-
New hope for tough lung cancers: targeted drug shows promise in Late-Stage trial
Disease control CompletedThis study tested a new drug called DS-1062a in 137 adults with advanced or spreading non-small cell lung cancer that has certain gene changes. Participants had already tried targeted therapy and platinum chemotherapy without success. The main goal was to see how many people's tu…
Matched conditions: NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Apr 28, 2026 23:51 UTC
-
New cocktail of cancer drugs tested for safety in advanced tumors
Disease control CompletedThis early-stage study tested the safety of combining multiple cancer drugs (niraparib, TSR-022, bevacizumab, chemotherapy, and TSR-042) in 60 people with advanced or metastatic solid tumors. The goal was to find safe doses for future studies. Participants had different types of …
Matched conditions: NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated Apr 28, 2026 23:50 UTC
-
Engineered immune cells take on advanced lung cancer in early trial
Disease control CompletedThis early-phase trial tested a new treatment for people with advanced non-small cell lung cancer that had grown or returned after standard therapy. Researchers took participants' own immune cells, genetically modified them in a lab to target cancer cells, and infused them back a…
Matched conditions: NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Adaptimmune • Aim: Disease control
Last updated Apr 28, 2026 23:50 UTC
-
Chemo injection directly into lung tumors shows promise in early trial
Disease control CompletedThis early-phase study tested a new method of delivering the chemotherapy drug cisplatin directly into lung tumors during a bronchoscopy procedure. Six adults with early-stage, operable non-small cell lung cancer participated to find the safest dose. The main goal was to identify…
Matched conditions: NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: University of Vermont • Aim: Disease control
Last updated Apr 28, 2026 23:50 UTC
-
New cell combo shows promise in early lung cancer safety trial
Disease control CompletedThis early-stage study tested a new cell therapy called PB101, made from the patient's own immune cells, combined with a standard targeted pill (EGFR-TKI) for people with advanced EGFR-mutated non-small cell lung cancer. The main goal was to check if the combination was safe and …
Matched conditions: NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Precision Biotech Taiwan Corp. • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
New antibody drug shows promise in early cancer trial
Disease control CompletedThis early-phase study tested a new drug called CHS-388 in 145 people with advanced solid tumors (kidney, liver, or lung cancer) that had stopped responding to standard treatments. The drug works by blocking a protein called IL-27 to help the immune system fight cancer. Researche…
Matched conditions: NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated Apr 28, 2026 13:01 UTC
-
Blood test boosts gene detection in lung cancer study
Knowledge-focused CompletedThis study looked at whether adding a simple blood test (liquid biopsy) to the standard tissue biopsy helps doctors find more gene changes (EGFR mutations) in people with advanced non-small cell lung cancer. Over 500 patients who had not yet been treated took part. The goal was t…
Matched conditions: NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Apr 28, 2026 23:51 UTC
-
Polish hospital records reveal Real-World impact of Immuno-Chemo combo for lung cancer
Knowledge-focused CompletedThis study looked back at medical records of 240 adults in Poland with advanced non-small cell lung cancer who received a combination of two immunotherapy drugs (nivolumab and ipilimumab) plus chemotherapy as their first treatment. Researchers wanted to see how patients responded…
Matched conditions: NON-SMALL CELL LUNG CANCER
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Apr 28, 2026 23:50 UTC